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ABSTRACT 
Pulmonary involvement in tuberous sclerosis is very rare and seems to be associated with a more benign course. We 
present a 21-year-old woman with bilateral angiomyolipoma. She developed spontaneous pneumothorax which was 
successfully managed by tube thoracostomy. No recurrence of pneumothorax has been observed up to the present (4 years 
follow-up). (Tanaffos 2009; 8(2): 64-68) 
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INTRODUCTION 
Tuberous sclerosis (TS) is a rare autosomal 
dominant disorder recognized mainly for its 
dermatological and neurological manifestations. Its 
approximate incidence is about 1 in 500,000 live 
births (1). Lesions of the kidney, lung, bone, heart, 
liver, ovary, spleen, adrenal, thyroid and pancreas 
have been described. The renal lesions most 
commonly associated with TS are angiomyolipoma 
and epithelial cyst, which are often multiple and 
bilateral, and may occur singly or in combination 
(2,3). The prevalence of renal angiolipoma in cases 
with TS is estimated to be 40 to 80% (3,4). 
Estimates of the fraction of patients with tuberous  
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sclerosis who have lung disease vary widely from <1 
to over 50 percent (5-7). There is a marked female 
predominance when pulmonary involvement is 
present (8). Most affected individuals present with 
dyspnea. In some, the onset is heralded by a 
spontaneous pneumothorax, which eventually occurs 
in approximately one-third of patients (9,10). 
Hemoptysis and chest pain are important symptoms 
as well and chylothorax is a rare complication 
(11,12). 
We report a young woman with angiomyolipoma, 
TS and dermatologic manifestations who presented 
with spontaneous hydropneumothorax as the first 
sign of pulmonary involvement that was managed by 
tube thoracostomy. 
 
CASE SUMMARY 
A 21-year-old non-smoking female presented 
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with a 2-week history of shortness of breath and left- 
sided chest pain. She had a history of seizures, facial 
angiofibroma, shagreen patches on the trunk, and 
hypopigmented patches on the abdomen, trunk and 
right foot since childhood. Her family history was 
negative for seizures. She had never used oral 
contraception but had been using medications for 
seizures. 
Her temperature was 37.6 oC, pulse rate was 
115/min., and respiration rate was 28/min. Her blood 
pressure was 110/70 mmHg. 
Physical examination was notable for decreased 
breath sounds over the left hemithorax. Laboratory 
findings: white blood cell count was 11,700 per cubic 
millimeter, with 76% neutrophils and 24% 
mononuclear cells. The levels of hemoglobin, blood 
urea nitrogen, creatinine and electrolytes were 
normal, as were the hematocrit, platelet count and 
blood sugar. 
A sample of arterial blood drawn while the patient 
was breathing room air revealed that the partial 
pressure of oxygen was 55 mmHg. Chest-x-ray 
showed a 100% left pneumothorax with a mild 
hydrothorax at the same side (Fig. 1). 
Tube thoracostomy was performed and the left 
lung was completely re-expanded. Computed 
Tomography scanning of the abdomen disclosed a 
mass with a predominantly fatty density, 6.5 by 4.7 
cm, in the lower pole of the right kidney, and a 
similar mass, 2.4 by 2.8 cm in the lower pole of the 
left kidney.  
The size and volumes of the two kidneys were 
larger than normal (Fig. 2). Brain CT-scan obtained 
without the intravenous administration of contrast 
material, showed focal calcifications in the right 
cerebellum and paraventricular area (Fig. 3). 
Echocardiography of the heart was reported normal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The posteroanterior chest radiograph reveals a large 
collection of air gas in the left hemithorax. The heart and mediastinum 
are shifted towards the left side of hemithorax. Blunting of the left 
costophrenic angle is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. CT-scan of the abdomen, demonstrating a mass, 6.5 by 4.7 
cm in the lower pole of the right kidney, and another mass 2.4 by 2.8 cm 
in the lower pole of the left kidney. The density of the masses is 
predominantly fatty. 
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Figure 3. CT-scan of the brain, revealing calcifications in the right 
cerebellum and paraventricular area. 
 
DISCUSSION 
The pulmonary manifestations of tuberous 
sclerosis are indistinguishable from those of 
lymphangioleiomyomatosis (LAM) (9). 
The clinical, radiographic and pathological 
findings are similar to pulmonary 
lymphangioleiomyomatosis and pulmonary tuberous 
sclerosis. However, these diseases can be 
distinguished by features such as seizures or skin 
lesions, which are usual in TS and always absent in 
LAM (13). 
TS affects males and females equally; whereas, 
LAM occurs only in females. Pulmonary 
involvement, which is frequent in LAM, almost 
always occurs in premenopausal women with TS, 
and thus this condition seems to depend on hormonal 
influences. In a review of the literature published in 
1972, 28 well-documented cases were identified, 27 
in women ranging in age from 21 to 50 years (14). 
Clinical manifestations of pulmonary involvement 
are also similar to those of LAM. Respiratory 
symptoms are usually first noticed between 20 and 
45 years of age (15). In a series of 9 patients, 
pneumothorax complicated the course of disease in 
four (15).  
Another study screened 23 asymptomatic women 
with TS for pulmonary involvement using thoracic 
CT-scan. The overall prevalence of abnormal 
findings on CT-scan was 52 percent.  Nodular 
changes were noted in 10 patients (43%). 
Characteristic cystic changes were present in 9 
patients (39%). All nine had angiomyolipomas (6). 
Lung function studies reveal hypoxemia, 
obstructive and restrictive patterns of ventilation and 
decreased DLCO. 
In many cases, the symptoms deteriorate during 
the menstruation period or in the course of a 
pregnancy (16,17). Pulmonary involvement in 
tuberous sclerosis carries a poor prognosis, with 
progressive disease being common. Death occurs 
secondary to respiratory insufficiency, often within 
five years of the onset of symptoms. 
Pulmonary TS affects women almost exclusively, 
who rarely suffer from mental retardation and who 
usually have a better life expectancy than patients 
with TS (18). On the other hand, there are some 
striking similarities between patients with pulmonary 
TS and LAM: affected patients are women in the 
childbearing age, in which pneumothorax often 
occurs (18). The pathologic characteristics of TS and 
LAM are virtually identical in most cases (19). 
In LAM, chylothorax is a frequent complication 
(17,19); whereas, angiomyolipoma often occurs in 
pulmonary TS (20). Similar to LAM, pneumothorax 
is common, being reported in up to 50% of patients 
who have TS and pulmonary involvement (15). 
The most common manifestations of kidney 
involvement in TS are renal hamartoma 
(angiomyolipoma) and cysts, occurring in 50 to 80% 
of cases (3,4). Although most patients remain 
asymptomatic, as in this case, symptoms may occur 
with increasing size, rupture of hemorrhage, 
replacement of normal renal parenchyma or 
impingement on juxtaposed structures. 
The exact incidence of renal cysts is unknown 
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because they are often asymptomatic (2). These cysts 
have been implicated as the cause of renal 
insufficiency, chronic renal failure and 
hyperreninemic hypertension, which have been 
reported to be the earliest signs of TS in young 
children (21). The diagnosis of TS should be 
considered when bilateral renal angiomyolipomas are 
characteristic appearance of mixed fat and soft tissue 
attenuation on CT-scan. Extrathoracic manifestations 
of TS are seen in virtually all patients and most 
commonly include seizures, renal angiomyolipoma, 
cerebral calcification, skin lesions, and retinal 
hamartoma (15). 
Pulmonary lesions have demonstrated some 
response to hormonal manipulation. Hormone-
modulating treatment in TS can be started with 
androgen (22), then with oophorectomy (17), 
followed by antiestrogen therapy with tamoxifen 
(23), or medroxyprogesterone (25,26), or both (25). 
Available therapies have to be regarded as 
experimental, due to the lack of control studies.  
However, hormonal treatments seem to be most 
appropriate in the context of previous hormonal 
dependence of the disease, demonstration of steroid 
receptors in involved lung parenchyma (16,23,25) 
and clinical exacerbation with discontinuation of 
steroid therapy in some patients (25). 
At this time, the most successful therapy for 
pulmonary TS or LAM is lung transplantation in end-
stage disease. The benefits of hormonal 
manipulations are documented only by means of 
pulmonary function or blood gas data and not by 
chest CT data or survival rate. Hormonal treatments 
have no effect on cystic changes and honeycombing, 
based on some reports on hormonal treatment for 
lymphangioleiomyomatosis in patients with TS 
(24,27). 
Tamoxifen treatment succeeded in one patient, 
progesterone treatment failed in another, and 
treatment with both medications failed in two (24). 
In this patient, pneumothorax resolved with chest 
tube. It has been four years since the treatment and 
the pulmonary and renal function of the patient have 
been stable.  
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